Terapia Celular Adoptiva
Icahn School of Medicine at Mount Sinai
Nueva York, Estados UnidosPublicaciones en colaboración con investigadores/as de Icahn School of Medicine at Mount Sinai (2)
2021
-
CD137 and PD-L1 targeting with immunovirotherapy induces a potent and durable antitumor immune response in glioblastoma models
Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 7
2019
-
Genetic Modification of CD8+ T Cells to Express EGFR: Potential Application for Adoptive T Cell Therapies
Frontiers in Immunology, Vol. 10